Search
education › ... › admissions
… will host a virtual information session on Dec. 15, 2026. This is an opportunity to learn about the program and … July 1, 2026 … September 2026 … Oct. 15, 2026 … Nov. 15, 2026 … through the online application portal by July 1, 2026. … and also violates College policy (02.2.25, 02.2.26) and will not be tolerated. In some circumstances, such …
education › ... › admissions
… June 1, 2026 – Application Deadline June 15, 2026 – Supporting Documents Deadline Aug. 11, 13 and 15, 2026 – Personal Interviews of Invited Applicants Late August – … and also violates College policy (02.2.25, 02.2.26) and will not be tolerated. In some circumstances, such …
about-us › ... › expanding-our-role-in-promoting-trust-in-science-for-covid-19-vaccine-acceptance-and-beyond
… and trust that decisions are being made in the interest of protecting the health and well-being of all people … freedom” protests . Currently, surveys suggest nearly 30% of Americans would decline a COVID-19 vaccine if … information. Below are efforts we support, building off of existing recommendations from Dr. Peter Hotez, dean …
healthcare › clinical-trials › h-42584
… concurrently with definitive regional radiotherapy for treatment of cervical cancer. … Study of niraparib with radiotherapy for treatment of metastatic invasive carcinoma of the cervix …
healthcare › clinical-trials › h-49648
… GEKO as an adjunct for the treatment of lower extremity edema in acute heart …
healthcare › clinical-trials › h-46767
… and evaluate genomic biomarkers found in menstrual fluid for the development of a non-invasive diagnostic test for uterine disorders such as endometriosis and adenomyosis, … staging and classification of disease. A non-invasive test for uterine disorders would fundamentally change how these …
news › tumor-induced-b-cell-changes-reveal-potential-biomarker-for-treatment-response-in-triple-negative-breast-cancer
… B cell abnormalities that could serve as blood biomarkers for determining likelihood of response to standard-of-care … TiBA-1, has a reduced number of B cells, likely due to competition with myeloid progenitors in the bone marrow … In a study of 35 patients, 78.6% of TiBA-0 patients had a complete response to treatment with chemotherapy and …
news › dr-mary-dickinson-named-a-2023-fellow-by-the-american-association-for-the-advancement-of-science
… has been named a 2023 Fellow by the American Association for the Advancement of Science . This honor comes as AAAS celebrates its 150th anniversary of the … named a Fellow is a lifetime honor within the scientific community. Dickinson is being recognized for her …
healthcare › clinical-trials › h-56035
… This phase II/III trial compares the addition of nivolumab to the usual treatment of … treat patients with advanced stomach or esophageal cancer. For more information: https://clinicaltrials.gov/study/NCT06203600 … PARAMUNE Trial: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer …
healthcare › ... › endoscopy
… All patients will be informed at the time of their visit of the potential need for an endoscopic evaluation, …